Cargando…

Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents

A new series of 3-acetyl-1,3,4-oxadiazoline hybrid molecules was designed and synthesized using a condensation between acyclonucleosides and substituted phenylhydrazone. All intermediates and final products were screened against Leishmania donovani, a Protozoan parasite and against three viruses SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lachhab, Saida, El Mansouri, Az-eddine, Mehdi, Ahmad, Dennemont, Indira, Neyts, Johan, Jochmans, Dirk, Andrei, Graciela, Snoeck, Robert, Sanghvi, Yogesh S., Ait Ali, Mustapha, Loiseau, Philippe M., Lazrek, Hassan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573813/
https://www.ncbi.nlm.nih.gov/pubmed/36251201
http://dx.doi.org/10.1007/s11030-022-10548-9
_version_ 1784810963993624576
author Lachhab, Saida
El Mansouri, Az-eddine
Mehdi, Ahmad
Dennemont, Indira
Neyts, Johan
Jochmans, Dirk
Andrei, Graciela
Snoeck, Robert
Sanghvi, Yogesh S.
Ait Ali, Mustapha
Loiseau, Philippe M.
Lazrek, Hassan B.
author_facet Lachhab, Saida
El Mansouri, Az-eddine
Mehdi, Ahmad
Dennemont, Indira
Neyts, Johan
Jochmans, Dirk
Andrei, Graciela
Snoeck, Robert
Sanghvi, Yogesh S.
Ait Ali, Mustapha
Loiseau, Philippe M.
Lazrek, Hassan B.
author_sort Lachhab, Saida
collection PubMed
description A new series of 3-acetyl-1,3,4-oxadiazoline hybrid molecules was designed and synthesized using a condensation between acyclonucleosides and substituted phenylhydrazone. All intermediates and final products were screened against Leishmania donovani, a Protozoan parasite and against three viruses SARS-CoV-2, HCMV and VZV. While no significant activity was observed against the viruses, the intermediate with 6-azatymine as thymine and 5-azathymine-3-acetyl-1,3,4-oxadiazoline hybrid exhibited a significant antileishmanial activity. The later compound was the most promising, exhibiting an IC(50) value at 8.98 µM on L. donovani intramacrophage amastigotes and a moderate selectivity index value at 2.4. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11030-022-10548-9.
format Online
Article
Text
id pubmed-9573813
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-95738132022-10-17 Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents Lachhab, Saida El Mansouri, Az-eddine Mehdi, Ahmad Dennemont, Indira Neyts, Johan Jochmans, Dirk Andrei, Graciela Snoeck, Robert Sanghvi, Yogesh S. Ait Ali, Mustapha Loiseau, Philippe M. Lazrek, Hassan B. Mol Divers Original Article A new series of 3-acetyl-1,3,4-oxadiazoline hybrid molecules was designed and synthesized using a condensation between acyclonucleosides and substituted phenylhydrazone. All intermediates and final products were screened against Leishmania donovani, a Protozoan parasite and against three viruses SARS-CoV-2, HCMV and VZV. While no significant activity was observed against the viruses, the intermediate with 6-azatymine as thymine and 5-azathymine-3-acetyl-1,3,4-oxadiazoline hybrid exhibited a significant antileishmanial activity. The later compound was the most promising, exhibiting an IC(50) value at 8.98 µM on L. donovani intramacrophage amastigotes and a moderate selectivity index value at 2.4. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11030-022-10548-9. Springer International Publishing 2022-10-17 /pmc/articles/PMC9573813/ /pubmed/36251201 http://dx.doi.org/10.1007/s11030-022-10548-9 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Lachhab, Saida
El Mansouri, Az-eddine
Mehdi, Ahmad
Dennemont, Indira
Neyts, Johan
Jochmans, Dirk
Andrei, Graciela
Snoeck, Robert
Sanghvi, Yogesh S.
Ait Ali, Mustapha
Loiseau, Philippe M.
Lazrek, Hassan B.
Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
title Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
title_full Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
title_fullStr Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
title_full_unstemmed Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
title_short Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
title_sort synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573813/
https://www.ncbi.nlm.nih.gov/pubmed/36251201
http://dx.doi.org/10.1007/s11030-022-10548-9
work_keys_str_mv AT lachhabsaida synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT elmansouriazeddine synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT mehdiahmad synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT dennemontindira synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT neytsjohan synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT jochmansdirk synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT andreigraciela synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT snoeckrobert synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT sanghviyogeshs synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT aitalimustapha synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT loiseauphilippem synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents
AT lazrekhassanb synthesisofnew3acetyl134oxadiazolinescombinedwithpyrimidinesasantileishmanialandantiviralagents